Swedbank’s PhenomeX Inc. Common Stock CELL Stock Holding History

Swedbank’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,500,000	Closed	-$2.5M	–	726
2023 Q3	$2.5M	Hold	2,500,000	–	–	﹤0.01%	572
2023 Q2	$1.23M	Buy	2,500,000 +200,000	+9%	+$164K	﹤0.01%	621
2023 Q1	$2.67M	Buy	2,300,000 +431,200	+23%	+$788K	0.01%	581
2022 Q4	$5.01M	Buy	1,868,800 +368,800	+25%	+$972K	0.01%	496
2022 Q3	$4.29M	Hold	1,500,000	–	–	0.01%	519
2022 Q2	$7.46M	Buy	1,500,000 +100,000	+7%	+$524K	0.02%	464
2022 Q1	$9.95M	Buy	1,400,000 +330,000	+31%	+$2.73M	0.02%	444
2021 Q4	$19.9M	Buy	1,070,000 +69,800	+7%	+$1.51M	0.03%	346
2021 Q3	$19.6M	Buy	+1,000,200	New	+$38M	0.04%	346

Swedbank's CELL Position: Q4 2023 in Review

Swedbank sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 2,500,000 shares — an estimated $2.5M sold.

Swedbank first reported a position in CELL in Q3 2021 and held it in 9 quarters. The position peaked at $19.9M in Q4 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

Swedbank reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Swedbank sold 2,500,000 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $2.5M.
Swedbank first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 9 quarters.
Swedbank's PhenomeX Inc. Common Stock position peaked at $19.9M in Q4 2021.
0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Swedbank's 13F filing for Q4 2023, filed 6 Dec 2024.